BIOCRYST PHARMACEUTICALS INC - FORM 10-K - EX-23 - CONSENT OF ERNST & YOUNG, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 6, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - BIOCRYST PHARMACEUTICALS INCFinancial_Report.xls
10-K - FORM 10-K - BIOCRYST PHARMACEUTICALS INCd306545d10k.htm
EX-21 - SUBSIDIARIES OF THE REGISTRANT - BIOCRYST PHARMACEUTICALS INCd306545dex21.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - BIOCRYST PHARMACEUTICALS INCd306545dex321.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - BIOCRYST PHARMACEUTICALS INCd306545dex312.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - BIOCRYST PHARMACEUTICALS INCd306545dex311.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - BIOCRYST PHARMACEUTICALS INCd306545dex322.htm
EX-10.32 - AMENDED AND RESTATED DEVELOPEMENT AND LICENSE AGREEMENT - BIOCRYST PHARMACEUTICALS INCd306545dex1032.htm
EX-10.36 - FIFTH AMENDMENT AGREEMENT - BIOCRYST PHARMACEUTICALS INCd306545dex1036.htm

Exhibit 23

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

 

  Ÿ  

Registration Statements (Form S-8 Nos. 333-120345, 333-39484 and 333-30751) pertaining to the BioCryst Pharmaceuticals, Inc. 1991 Stock Option Plan, as amended and restated as of March 8, 2004;

 

  Ÿ  

Registration Statement (Form S-8 No. 333-90582) pertaining to the BioCryst Pharmaceuticals, Inc. Employee Stock Purchase Plan;

 

  Ÿ  

Registration Statement (Form S-8 No. 333-136703) pertaining to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, which amended and restated the BioCryst Pharmaceuticals, Inc. 1991 Stock Option Plan as of May 17, 2006;

 

  Ÿ  

Registration Statement (Form S-3 No. 333-145638) pertaining to the registration of up to 8,140,000 shares of common stock;

 

  Ÿ  

Registration Statement (Form S-8 No. 333-145627) pertaining to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan as amended and restated effective March 2007 and Employment Letter Agreement dated April 2, 2007 between BioCryst Pharmaceuticals, Inc. and David McCullough;

 

  Ÿ  

Registration Statement (Form S-3 No. 333-175182) for the registration of up to $70 million of BioCryst Pharmaceuticals, Inc. common stock, preferred stock, depositary shares, stock purchase contracts, warrants or units;

 

  Ÿ  

Registration Statement (Form S-3 No. 333-153084) for the registration of 3,335,408 shares of BioCryst Pharmaceuticals, Inc. common stock and 3,159,895 warrants to purchase common stock of BioCryst Pharmaceuticals, Inc.;

 

  Ÿ  

Registration Statement (Form S-8 No. 333-152570) pertaining to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated effective February 28, 2008 and the BioCryst Pharmaceuticals, Inc. Employee Stock Purchase Plan, as amended and restated effective February 28, 2008.

 

  Ÿ  

Registration Statement (Form S-8 No. 333-167830) pertaining to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated effective March 31, 2010 and the BioCryst Pharmaceuticals, Inc. Employee Stock Purchase Plan, as amended and restated effective March 31, 2010.

 

  Ÿ  

Registration Statement (Form S-8 No. 333-176096) pertaining to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated effective February 17, 2011.

of our reports dated March 6, 2012 with respect to the consolidated financial statements of BioCryst Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of BioCryst Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2011.

/s/    Ernst & Young LLP

Raleigh, North Carolina

March 6, 2012

BIOCRYST PHARMACEUTICALS INC Reports